SPIROCYCLIC AMILORIDE ANALOGUES AS ENAC BLOCKERS

A compound of Formula I in free or salt or solvate form, where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel. In particular, airwa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CATHERINE HOWSHAM, PAUL OAKLEY, EMMA BUDD, PETER HUNT, NICHOLA SMITH, GURDIP BHALAY, STEPHEN PAUL COLLINGWOOD, ANDREW DUNSTAN, LEE EDWARDS, PETER GEDECK, GRAHAM CHARLES BLOOMFIELD, THOMAS ANTHONY HUNT
Format: Patent
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CATHERINE HOWSHAM
PAUL OAKLEY
EMMA BUDD
PETER HUNT
NICHOLA SMITH
GURDIP BHALAY
STEPHEN PAUL COLLINGWOOD
ANDREW DUNSTAN
LEE EDWARDS
PETER GEDECK
GRAHAM CHARLES BLOOMFIELD
THOMAS ANTHONY HUNT
description A compound of Formula I in free or salt or solvate form, where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel. In particular, airway diseases like COPD and cystic fibrosis are treatable, but also inflammatory and allergic diseases. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT2444120TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT2444120TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT2444120TT3</originalsourceid><addsrcrecordid>eNrjZDAIDvAM8neOdPbxdFZw9PX08Q_ydHFVcPRz9PF3D3UNVnAMVnD1c3RWcPLxd_Z2DQrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxASFGJiYmhkYGISHGRCgBAOqRJkQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SPIROCYCLIC AMILORIDE ANALOGUES AS ENAC BLOCKERS</title><source>esp@cenet</source><creator>CATHERINE HOWSHAM ; PAUL OAKLEY ; EMMA BUDD ; PETER HUNT ; NICHOLA SMITH ; GURDIP BHALAY ; STEPHEN PAUL COLLINGWOOD ; ANDREW DUNSTAN ; LEE EDWARDS ; PETER GEDECK ; GRAHAM CHARLES BLOOMFIELD ; THOMAS ANTHONY HUNT</creator><creatorcontrib>CATHERINE HOWSHAM ; PAUL OAKLEY ; EMMA BUDD ; PETER HUNT ; NICHOLA SMITH ; GURDIP BHALAY ; STEPHEN PAUL COLLINGWOOD ; ANDREW DUNSTAN ; LEE EDWARDS ; PETER GEDECK ; GRAHAM CHARLES BLOOMFIELD ; THOMAS ANTHONY HUNT</creatorcontrib><description>A compound of Formula I in free or salt or solvate form, where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel. In particular, airway diseases like COPD and cystic fibrosis are treatable, but also inflammatory and allergic diseases. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</description><language>eng ; por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180103&amp;DB=EPODOC&amp;CC=PT&amp;NR=2444120T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180103&amp;DB=EPODOC&amp;CC=PT&amp;NR=2444120T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CATHERINE HOWSHAM</creatorcontrib><creatorcontrib>PAUL OAKLEY</creatorcontrib><creatorcontrib>EMMA BUDD</creatorcontrib><creatorcontrib>PETER HUNT</creatorcontrib><creatorcontrib>NICHOLA SMITH</creatorcontrib><creatorcontrib>GURDIP BHALAY</creatorcontrib><creatorcontrib>STEPHEN PAUL COLLINGWOOD</creatorcontrib><creatorcontrib>ANDREW DUNSTAN</creatorcontrib><creatorcontrib>LEE EDWARDS</creatorcontrib><creatorcontrib>PETER GEDECK</creatorcontrib><creatorcontrib>GRAHAM CHARLES BLOOMFIELD</creatorcontrib><creatorcontrib>THOMAS ANTHONY HUNT</creatorcontrib><title>SPIROCYCLIC AMILORIDE ANALOGUES AS ENAC BLOCKERS</title><description>A compound of Formula I in free or salt or solvate form, where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel. In particular, airway diseases like COPD and cystic fibrosis are treatable, but also inflammatory and allergic diseases. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAIDvAM8neOdPbxdFZw9PX08Q_ydHFVcPRz9PF3D3UNVnAMVnD1c3RWcPLxd_Z2DQrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxASFGJiYmhkYGISHGRCgBAOqRJkQ</recordid><startdate>20180103</startdate><enddate>20180103</enddate><creator>CATHERINE HOWSHAM</creator><creator>PAUL OAKLEY</creator><creator>EMMA BUDD</creator><creator>PETER HUNT</creator><creator>NICHOLA SMITH</creator><creator>GURDIP BHALAY</creator><creator>STEPHEN PAUL COLLINGWOOD</creator><creator>ANDREW DUNSTAN</creator><creator>LEE EDWARDS</creator><creator>PETER GEDECK</creator><creator>GRAHAM CHARLES BLOOMFIELD</creator><creator>THOMAS ANTHONY HUNT</creator><scope>EVB</scope></search><sort><creationdate>20180103</creationdate><title>SPIROCYCLIC AMILORIDE ANALOGUES AS ENAC BLOCKERS</title><author>CATHERINE HOWSHAM ; PAUL OAKLEY ; EMMA BUDD ; PETER HUNT ; NICHOLA SMITH ; GURDIP BHALAY ; STEPHEN PAUL COLLINGWOOD ; ANDREW DUNSTAN ; LEE EDWARDS ; PETER GEDECK ; GRAHAM CHARLES BLOOMFIELD ; THOMAS ANTHONY HUNT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT2444120TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>CATHERINE HOWSHAM</creatorcontrib><creatorcontrib>PAUL OAKLEY</creatorcontrib><creatorcontrib>EMMA BUDD</creatorcontrib><creatorcontrib>PETER HUNT</creatorcontrib><creatorcontrib>NICHOLA SMITH</creatorcontrib><creatorcontrib>GURDIP BHALAY</creatorcontrib><creatorcontrib>STEPHEN PAUL COLLINGWOOD</creatorcontrib><creatorcontrib>ANDREW DUNSTAN</creatorcontrib><creatorcontrib>LEE EDWARDS</creatorcontrib><creatorcontrib>PETER GEDECK</creatorcontrib><creatorcontrib>GRAHAM CHARLES BLOOMFIELD</creatorcontrib><creatorcontrib>THOMAS ANTHONY HUNT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CATHERINE HOWSHAM</au><au>PAUL OAKLEY</au><au>EMMA BUDD</au><au>PETER HUNT</au><au>NICHOLA SMITH</au><au>GURDIP BHALAY</au><au>STEPHEN PAUL COLLINGWOOD</au><au>ANDREW DUNSTAN</au><au>LEE EDWARDS</au><au>PETER GEDECK</au><au>GRAHAM CHARLES BLOOMFIELD</au><au>THOMAS ANTHONY HUNT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SPIROCYCLIC AMILORIDE ANALOGUES AS ENAC BLOCKERS</title><date>2018-01-03</date><risdate>2018</risdate><abstract>A compound of Formula I in free or salt or solvate form, where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel. In particular, airway diseases like COPD and cystic fibrosis are treatable, but also inflammatory and allergic diseases. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; por
recordid cdi_epo_espacenet_PT2444120TT
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title SPIROCYCLIC AMILORIDE ANALOGUES AS ENAC BLOCKERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T10%3A53%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CATHERINE%20HOWSHAM&rft.date=2018-01-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT2444120TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true